(Total Views: 508)
Posted On: 04/24/2020 11:13:11 AM
Post# of 145254
Yea they already submitted BLA for GVHD for review in Sept, seems there drug is focused only on ARDS, not mild to moderate patients like Leronlimab.
http://investorsmedia.mesoblast.com/static-fi...87607948b6
http://investorsmedia.mesoblast.com/static-fi...87607948b6
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)